Friday, December 09, 2022 11:02:18 PM
SHORT INTEREST......................................... UP (17%) SHORTS HAVE 11.9 Millon shares shorted
Real-Time
After-Hours
Pre-Market
Charts
NEWS & ANALYSIS
News
Press Releases
Analyst Research
Dividend History
Historical Quotes
Historical NOCP
Financials
Earnings
P/E & PEG Ratios
Option Chain
Short Interest
Institutional Holdings
Insider Activity
SEC Filings
Revenue EPS
AVXL AVXL SHORT INTEREST
AVXL Short Interest
SETTLEMENT DATE SHORT INTEREST AVG. DAILY SHARE VOLUME DAYS TO COVER
11/30/2022 11,914,762 1,787,726 6.664758
11/15/2022 10,167,456 986,389 10.307755
10/31/2022 10,105,713 985,598 10.253382
10/14/2022 10,043,451 718,819 13.972156
09/30/2022 10,260,594 936,366 10.957888
09/15/2022 9,737,900 683,304 14.251197
08/31/2022 9,102,975 706,411 12.886231
08/15/2022 8,428,105 784,854 10.738437
07/29/2022 8,726,226 855,980 10.194427
07/15/2022 8,260,601 918,653 8.99208
06/30/2022 8,707,363 1,190,086 7.316583
06/15/2022 9,497,126 821,200 11.564937
05/31/2022 8,908,532 807,482 11.032484
05/13/2022 8,775,909 1,049,795 8.359641
04/29/2022 8,133,566 762,827 10.662399
04/14/2022 7,880,667 703,388 11.203869
03/31/2022 7,614,059 1,065,822 7.143837
03/15/2022 8,040,824 973,062 8.263424
02/28/2022 7,848,021 1,031,931 7.60518
02/15/2022 7,854,386 2,073,421 3.788129
01/31/2022 5,855,106 1,160,763 5.044187
01/14/2022 4,843,442 1,004,591 4.821307
12/31/2021 4,496,477 927,729 4.846757
12/15/2021 4,831,346 918,225 5.261615
BACK TO AVXL OVERVIEW
NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then released on a dissemination date after 4 p.m. ET.
Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data.nasdaq.com.
About Short Interest
Nasdaq provides information of company’s short interest and the average days it takes to cover them.
Short interest and days to cover can be used to indicate market sentiment and gauge the stock market in an investor’s analysis. Please note: If days to cover is between 0 and 1, it is rounded up to 1 on Nasdaq.com.
Real-Time
After-Hours
Pre-Market
Charts
NEWS & ANALYSIS
News
Press Releases
Analyst Research
Dividend History
Historical Quotes
Historical NOCP
Financials
Earnings
P/E & PEG Ratios
Option Chain
Short Interest
Institutional Holdings
Insider Activity
SEC Filings
Revenue EPS
AVXL AVXL SHORT INTEREST
AVXL Short Interest
SETTLEMENT DATE SHORT INTEREST AVG. DAILY SHARE VOLUME DAYS TO COVER
11/30/2022 11,914,762 1,787,726 6.664758
11/15/2022 10,167,456 986,389 10.307755
10/31/2022 10,105,713 985,598 10.253382
10/14/2022 10,043,451 718,819 13.972156
09/30/2022 10,260,594 936,366 10.957888
09/15/2022 9,737,900 683,304 14.251197
08/31/2022 9,102,975 706,411 12.886231
08/15/2022 8,428,105 784,854 10.738437
07/29/2022 8,726,226 855,980 10.194427
07/15/2022 8,260,601 918,653 8.99208
06/30/2022 8,707,363 1,190,086 7.316583
06/15/2022 9,497,126 821,200 11.564937
05/31/2022 8,908,532 807,482 11.032484
05/13/2022 8,775,909 1,049,795 8.359641
04/29/2022 8,133,566 762,827 10.662399
04/14/2022 7,880,667 703,388 11.203869
03/31/2022 7,614,059 1,065,822 7.143837
03/15/2022 8,040,824 973,062 8.263424
02/28/2022 7,848,021 1,031,931 7.60518
02/15/2022 7,854,386 2,073,421 3.788129
01/31/2022 5,855,106 1,160,763 5.044187
01/14/2022 4,843,442 1,004,591 4.821307
12/31/2021 4,496,477 927,729 4.846757
12/15/2021 4,831,346 918,225 5.261615
BACK TO AVXL OVERVIEW
NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then released on a dissemination date after 4 p.m. ET.
Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data.nasdaq.com.
About Short Interest
Nasdaq provides information of company’s short interest and the average days it takes to cover them.
Short interest and days to cover can be used to indicate market sentiment and gauge the stock market in an investor’s analysis. Please note: If days to cover is between 0 and 1, it is rounded up to 1 on Nasdaq.com.
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
